Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jacopo Vecchiet and Francesco Cipollone.
Jacopo Vecchiet
Connection Strength
0.569
Francesco Cipollone
  1. Efficacy of canakinumab in mild or severe COVID-19 pneumonia. Immun Inflamm Dis. 2021 06; 9(2):399-405.
    View in: PubMed
    Score: 0.231
  2. Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids. Microorganisms. 2020 Aug 31; 8(9).
    View in: PubMed
    Score: 0.225
  3. Smell and Taste in Severe CoViD-19: Self-Reported vs. Testing. Front Med (Lausanne). 2020; 7:589409.
    View in: PubMed
    Score: 0.057
  4. Canakinumab in a subgroup of patients with COVID-19. Lancet Rheumatol. 2020 Aug; 2(8):e457-ee458.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.